Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C

被引:37
作者
Ido, Y
Chang, KC
Lejeune, WS
Bjercke, RJ
Reiser, KM
Williamson, JR
Tilton, RG
机构
[1] Texas Biotechnol Corp, Dept Pharmacol, Houston, TX 77030 USA
[2] Texas Biotechnol Corp, Dept Immunol, Houston, TX USA
[3] Boston Univ, Diabet & Metab Unit, Boston, MA 02215 USA
[4] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[5] Univ Calif Davis, Sch Med, Dept Neurol Surg, Davis, CA 95616 USA
关键词
advanced glycation end products; albumin permeation; blood flow; diabetes; vascular endothelial growth factor;
D O I
10.1038/sj.mn.7800079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: These experiments were designed to elucidate mechanisms mediating, vascular dysfunction induced by advanced glycation end product, (AGEs), Methods: Skin chambers were mounted on the backs of Sprague-Dawley rats and 1 week later. granulation tissue that formed in the bottom of dir chamber was exposed twice daily for 7 days to glycated rat serum albumin in the presence and absence of inhibitors of reactive oxygen intermediates, nitric oxide synthase and guanylate cyclase, protein kinase C (PKC). and a neutralizing vascular endothelial growth factor (VEGF) antibody. Vascular I-125-albumin clearance and blood flow were quantified by use Of a double isotope-dilution technique and radiolabeled microspheres. respectively. Results: Albumin permeation and blood flow were increased dose-dependently to a maximum of 2 to 3 times controls by increasing, the extent of glucose modification, the concentration, or the duration of exposure to glycated albumin, These increases were significantly attenuated by probucol and superoxide dismutase, N-G-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase inhibitor. LY83583, a guanylate cyclase inhibitor, and LY333531, a beta -isoform-selective protein kinase C inhibitor. A neutralizing VEGF monoclonal antibody also markedly attenuated the permeability and blood flow increased induced by glycated albumin. Conclusions: These observations indicate potentially important role,, for oxygen free-radicals and nitric oxide in mediating permeability and blood flow changed induced by glycated proteins via mechanisms involving increased protein kinase C activity and VEGF production. Striking similarities in the mechanism by which hyperglycemia and glycated proteins induce vascular dysfunction suggest that a common pathway mediates effects of these different metabolic imbalances on vascular dysfunction.
引用
收藏
页码:251 / 263
页数:13
相关论文
共 55 条
[1]   Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells [J].
Bierhaus, A ;
Chevion, S ;
Chevion, M ;
Hofmann, M ;
Quehenberger, P ;
Illmer, T ;
Luther, T ;
Berentshtein, E ;
Tritschler, H ;
Muller, M ;
Wahl, P ;
Ziegler, R ;
Nawroth, PP .
DIABETES, 1997, 46 (09) :1481-1490
[2]   STEREOSPECIFIC MONOCLONAL-ANTIBODIES TO NICOTINE AND COTININE AND THEIR USE IN ENZYME-LINKED IMMUNOSORBENT ASSAYS [J].
BJERCKE, RJ ;
COOK, G ;
RYCHLIK, N ;
GJIKA, HB ;
VANVUNAKIS, H ;
LANGONE, JJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 90 (02) :203-213
[3]   Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo [J].
Bonnardel-Phu, E ;
Wautier, JL ;
Schmidt, AM ;
Avila, C ;
Vicaut, E .
DIABETES, 1999, 48 (10) :2052-2058
[4]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[5]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[6]   Advanced glycation end products, oxidant stress and vascular lesions [J].
Chappey, O ;
Dosquet, C ;
Wautier, MP ;
Wautier, JL .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) :97-108
[7]   INCREASE IN DIACYLGLYCEROL MASS IN ISOLATED GLOMERULI BY GLUCOSE FROM DENOVO SYNTHESIS OF GLYCEROLIPIDS [J].
CRAVEN, PA ;
DAVIDSON, CM ;
DERUBERTIS, FR .
DIABETES, 1990, 39 (06) :667-674
[8]   MODULATION OF VENULAR MICROVESSEL PERMEABILITY BY CALCIUM INFLUX INTO ENDOTHELIAL-CELLS [J].
CURRY, FE .
FASEB JOURNAL, 1992, 6 (07) :2456-2466
[9]   Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis [J].
Giardino, I ;
Fard, AK ;
Hatchell, DL ;
Brownlee, M .
DIABETES, 1998, 47 (07) :1114-1120
[10]   cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i [J].
He, P ;
Zeng, M ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (06) :H1865-H1874